המומחים שלנו

trueבתי חולים > הרצפלד > דף הבית > אודות > המומחים שלנו > ד"ר טטאינה ונדר

ד"ר טטאינה ונדר

סגנית מנהלת המרכז הרפואי ומנהלת היחידה לאשפוז יום שיקומי

שם:

ד"ר טטאינה ונדר

טלפון:

08-8595218

תפקידים ומינויים

  • סגנית מנהלת המרכז הרפואי גריאטרי שיקומי הרצפלד.
  • מנהלת היחידה לאשפוז יום שיקומי.​

התמחות

  • נוירולוגיה ורפואה פיזיקלית ושיקומי​ת, מנהל רפואי​.

השתלמויות

  • 1998-2006  Postgraduate Medical School, Tel-Aviv University (TAU), Courses of Neurology And Physical Medicine and Rehabilitation.
  • ​2005  Rehabilitation Summer School, Serakusa, Italy (1 week).
  • 2007  Course of Botox Injection Therapy, Neurological Department, Ichilov Medical Center.
  • 2010  Advanced EMG, Asaf  Harofe Medical Center.
  • 2011  Ethics in Clinical Reserch (GCP), Petah Tikva.
  • 2011  Advanced Cardiac Life Support (ACLS) Course. MDA and Tel-Aviv University.
  • 2014  ACLS course repeated  (different provider, Loewenstein Hospital).
  • 2013  Course of Management of Medical Department/Ambulatory Service, Israeli edical Association, Ramat Gan.
  • 2013  Course of National Insurance Institute, Kiryat Ono Academical College.
  • 2015  Course Impact for Head of Hospital Departments.
  • 2015  Course of Chief of Medical Department, Petach Tikwa.
  • 2016  Course "Goal setting & Gait analysis: advanced methods for a patient-centered.strategy in spasticity", Alcabideche, Portugal.
  • 2018  MHA, Bar Ilan University, Israel.​

פעילות אקדמית

  • Tutor of Medical Students, Instructor in Neurology, Ben Gurion University of Negev.
  • 2011  Member, committee for planning and organization of the postgraduate course in rehabilitation medicine. Postgraduate Medical School, Sackler School of Medicine, TAU.
  • 2011- 2014 Lecturer in postgraduate course in rehabilitation medicine. Postgraduate Medical School, Sackler School of Medicine, TAU.
  • 2013  Member of Examination Board of  Physical Medicine and Rehabilitation.
  • 2014  Participation in Medical Students Clinical Workshop, Loewenstein Rehabilitation Hospital.
  • 2014  Diploma of Honor, Israel Medical Association.
  • 2014  Tutor of Medical Students, Instructor in Physical Medicine and Rehabilitation, Tel Aviv University.
  • 2015 Participation in Medical Students Clinical Workshop, Harzfeld Medical Center.
  • 2017 Treasurer of Israeli Physical Medicine and Rehabilitation Association.

חברויות באיגודים וארגונים מקצועיים

  • חברת איגוד רפואה פיזיקלית ושיקום.
  • ​נציגת וועד איגוד השיקום.​

פרסומים נבחרים

  • 1. Valdman S, Vander T, Bersudsky M, Ifergane G, Wirguin I.
  • The Many Faces of the Guillain-Barre Syndrome.
  • Neurology 2000;54(Suppl 3):A368. (Presented at the Annual meeting of the American Academy of Neurology, San Diego).
  • 2. Vander T, Medvedovsky M, Hallevy H, Gozman G, Herishanu YO. Listeria monocytogenes meningitis in a patient with chronic hepatitis C, treated by interferon alfa and ribavirin. J Infect 2003; 46: 70-71.
  • 3. Vander T, Medvedovsky M, Herishanu YO. Encephalopathy induced by oral acyclovir in a patient with normal renal function. J Infect 2003; 46: 286.
  • 4. Vander T, Hallevy H, Ifergane G, Herishanu YO. Metformin induced encephalopathy without lactic acidosis. Diabet Med 2004; 21: 194-195.
  • 5. Vander T, Medvedovsky M, Valdman S, Herishanu YO. Peripheral facial paralysis and meningitis caused by Rickettsia typhi infection. Scand J Infect Dis 2003; 35: 886-887.
  • 6. Vander T, Ifergane G. Transient post-ictal urinary retention: Presentation of 3 cases. Eur J Neurol 2004; 11: 207-208..
  • 7. Vander T, Medvedovsky M, Duchanu L, Shelef I, Tomer A, Herishanu YO. Postmenopausal hormone replacement therapy and dural sinus thrombosis.
  • Eur J Neurol 2004; 11: 569-71.
  • 8. Vander T, Medvedovsky M, Herishanu YO. Epilepsia partialis continua possibly caused by cerebellar lesion. Cerebellum 2004; 3: 126-8.
  • 9. Vander T, Hallevy C, Alsaed I, Valdman S, Ifergane G, Wirguin I. Positive 14-3-3 protein in the patient with Hashimoto's encephalopathy. J Neurol 2004;250: 1273-4.
  • 10. Vander T, Odi H, Bluvstein V, Ronen J, Catz A. Carbamazepine toxicity following Oxybutynin and Dantrolene administration – A case report. Spinal cord 2005; 43: 252-5.
  • 11. Vander T, Kish B, Strauss S, Ronen J, Bluvstein V, Catz A.
  • Rupture of Quadriceps Tendon​ in a Patient with Postanoxic Choreo-athetosis. Disability and Rehabilitation 2005; 27: 597-599.
  • 12. Wirguin I, Vander T, Brenner T, Abramsky O, Steiner I. Improvement of SSPE by intrathecal infusion of alpha-IFN. Neurology 2005; 64: 402.
  • 13. Benmoyal-Segal L, Vander T, Shifman S, Bryk B, Ebstein R, Marcus EL, Stessman J, Darvasi A, Herishanu Y, Friedman A, Soreq H. Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease. FASEB J. 2005 Jan 3.
  • 14. Cohen AD, Vander T, Medvendovsky E, Biton A, Naimer S, Shalev R, Vardy DA Neuropathic scrotal pruritus: anogenital pruritus is a symptom of lumbosacral radiculopathy. J Am Acad Dermatol. 2005;52:61-6
  • 15. Hellden, A, Lycke , Vander T, Svensson Jan-Olof , Odar-Cederlof I, Stahle L.
  • The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment.
  • Journal of Antimicrobial Chemotherapy. 2006; 57(5):945-949
  • 16. Medvedovsky M, Ifergane G, Wirguin I, Vander T, Dori A, Kipervasser S, Shifrin A, Vakhapova-Danicek V, Neufeld MY.
  • Traumatic intracranial hemorrhage in patients with seizures: descriptive characteristics. Epilepsy Behav
  • 18. Perl O, Plotkin A, Weissbrod A, Oksenberg A, Vander T, Hairston I, Sobel N.
  • An odor-dispersing device for treatment of sleep apnea. J.Mol.Neurosci 2013, Suppl 1.

ניסיון קליני קודם

  • 2007-2015​ רופאה בכירה באישפוז יום שיקומי בי"ח לווינשטיין.

האם תוכן זה היה מועיל?

תגיות

אני רוצה...

לשלוח לחבר

להדפיס